How a tiny glass chip maps the hidden mutations driving human disease
In short: A DNA microarray acts as a diagnostic filter, using synthetic genetic sequences to detect mutations within an individual's blood. By comparing a patient's sample against a normal control, this technology reveals the specific genetic variations that contribute to complex conditions like hereditary breast and ovarian cancers.
At its core, a DNA microarray is a small glass or plastic plate featuring thousands of synthetic, single-stranded DNA sequences. These sequences represent both normal genes and known variants found in the human population. The technology relies on hybridization, where labeled DNA from a patient and a control sample bind to these synthetic probes. If an individual carries a mutation, their DNA will fail to bind to the 'normal' sequence on the chip, instead attaching to the specific probe representing the mutated version.
The process begins by isolating DNA from a patient's blood sample and a control sample. Researchers denature these samples to create single-stranded molecules, then cut them into manageable fragments. These fragments are labeled with fluorescent dyes—typically green for the patient and red for the control—before being introduced to the chip. The resulting binding patterns allow scientists to identify mutations that might otherwise be difficult to detect, especially in large genes like BRCA1, which alone contains over 800 known mutations.
While newer sequencing technologies have emerged, microarrays remain vital due to their cost-effectiveness, particularly for large-scale population studies and clinical diagnostics. Beyond mutation detection, they are used to analyze gene expression by measuring RNA transcripts, helping researchers understand which genes are active in specific tissues. This versatility allows clinicians to tailor drug prescriptions based on an individual's unique genetic chemistry, marking a significant shift toward personalized medicine.
The manufacturing of these chips often mirrors the methods used for computer microchips, allowing for high-density 'features' that represent a vast portion of the human genome. Although some tests have transitioned to direct sequencing, the ability of microarrays to process large datasets simultaneously ensures their continued relevance in both research and clinical settings, providing a scalable solution for identifying the genetic underpinnings of disease.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: DNA Microarray Technology Fact Sheet
- Also: DNA microarray
To cite this card, link to https://intellectplus.co.uk/app/technology-dna-microarray.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Biotechnology · More in Technology · Latest · A–Z · All topics